Rankings
▼
Calendar
PHIO Q1 2023 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena
PHIO
Phio Pharmaceuticals Corp.
$13M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$2M
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-28.41
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$111,000
Balance Sheet
Total Assets
$10M
Total Liabilities
$2M
Stockholders' Equity
$7M
Cash & Equivalents
$9M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$2M
-$2M
-34.6%
Operating Income
-$4M
-$3M
-36.4%
Net Income
-$4M
-$3M
-36.3%
← FY 2023
All Quarters
Q2 2023 →